FDA — authorised 16 August 1949
- Marketing authorisation holder: LEDERLE
- Status: approved
FDA authorised Sulfamerazin on 16 August 1949
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 16 August 1949.
LEDERLE holds the US marketing authorisation.